SCHEMBL2196166

SCHEMBL2196166

C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H]([C]=O)CC(N)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSC P53634 1/20 0.44
BMP1 P13497 3/20 0.42
BACE1 P56817 5/20 0.41
CTSD P07339 1/20 0.38
PDCD1LG2 Q9BQ51 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
ECE1 P42892 2/20 0.35
DPP4 P27487 1/20 0.35
DPP8 Q6V1X1 1/20 0.35
DPP9 Q86TI2 1/20 0.35
NAALAD2 Q9Y3Q0 1/20 0.35
GABRP O00591 2/20 0.35
GABRD O14764 2/20 0.35
GABRA1 P14867 2/20 0.35
GABRB1 P18505 2/20 0.35
GABRG2 P18507 2/20 0.35
GABRB3 P28472 2/20 0.35
GABRA5 P31644 2/20 0.35
GABRA3 P34903 2/20 0.35
GABRA2 P47869 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2190022 0.91 CTSC (0.39) CTSCBMP1BACE1CTSDPDCD1LG2
SCHEMBL7333594 0.85 CTSC (0.37) CTSCPDCD1LG2CD274ECE1DPP4
SCHEMBL23257073 0.85 CTSC (0.46) CTSCBMP1BACE1CTSDPDCD1LG2
SCHEMBL21365332 0.85 CTSC (0.46) CTSCBMP1BACE1CTSDPDCD1LG2
SCHEMBL21365331 0.85 CTSC (0.46) CTSCBMP1BACE1CTSDPDCD1LG2
SCHEMBL10796462 0.84 CTSC (0.52) CTSCDPP4DPP8DPP9NAALAD2
SCHEMBL2183259 0.84 BMP1 (0.45) BMP1BACE1CTSDDPP4DPP8
SCHEMBL30974391 0.82 CTSC (0.51) CTSCBMP1BACE1NAALAD2
SCHEMBL29873367 0.81 CTSC (0.48) CTSCBMP1BACE1NAALAD2
SCHEMBL11037525 0.81 CTSC (0.39) CTSCBMP1PDCD1LG2CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9173951-B2 Carbohydrate-based drug delivery polymers and conjugates thereof NEKTAR THERAPEUTICS (US) 2015-11-03 US disclosed
US-20150051371-A1 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF NEKTAR THERAPEUTICS (US) 2015-02-19 US disclosed
US-8680263-B2 Carbohydrate-based drug delivery polymers and conjugates thereof NEKTAR THERAPEUTICS (US) 2014-03-25 US disclosed
US-20110171716-A1 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF NEKTAR THERAPEUTICS (US) 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110171716-A1 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF STT3B, STT3A, DDOST CTSC 383/4885BMP1 2155/4885BACE1 3429/4885
US-20150051371-A1 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF STT3B, STT3A, DDOST CTSC 383/4885BMP1 2155/4885BACE1 3429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.